<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Medical Device Courses | Anthony | Mentions</title>
	<link>https://medicaldevicecourses.com/members/anthony/activity/mentions/</link>
	<atom:link href="https://medicaldevicecourses.com/members/anthony/activity/mentions/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed mentioning Anthony.</description>
	<lastBuildDate>Sat, 25 Apr 2026 00:06:59 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">84c78fb14096c8b40e4041f4d1c9fbe9</guid>
				<title>tm422 replied to the topic  &#034;FDA Approves First Digital Pill in USA&#034; -</title>
				<link>https://medicaldevicecourses.com/activity/p/30610/</link>
				<pubDate>Thu, 06 Feb 2025 01:54:47 -0500</pubDate>

									<content:encoded><![CDATA[<p><a href='https://medicaldevicecourses.com/members/anthony/' rel="nofollow ugc">@anthony</a> Hi Anthony! That is a very valid concern. The endorsement of Abilify MyCite highlights an important disparity between regulatory adherence and real-world clinical usefulness. Although the FDA’s responsibility is to confirm safety and adequate effectiveness, it does not always&#8230; &nbsp; <a href="https://medicaldevicecourses.com/forums/introduction-to-project-management/fda-approves-first-digital-pill-in-usa/paged/2/#post-20781" rel="nofollow ugc">Read more&raquo;</a></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>